Aimei Health Technology (NASDAQ:AFJK) Issues Earnings Results

Aimei Health Technology (NASDAQ:AFJK) issued its quarterly earnings data on Monday. The company reported $0.02 EPS for the quarter, FiscalAI reports.

Aimei Health Technology Price Performance

Shares of NASDAQ:AFJK traded down $1.13 during trading on Wednesday, reaching $43.86. 1,888 shares of the company’s stock traded hands, compared to its average volume of 24,652. Aimei Health Technology has a 12 month low of $6.75 and a 12 month high of $130.37. The company has a 50 day moving average of $34.55 and a 200-day moving average of $34.89. The stock has a market capitalization of $268.40 million, a P/E ratio of 208.85 and a beta of 0.46.

Institutional Investors Weigh In On Aimei Health Technology

A number of institutional investors have recently modified their holdings of AFJK. Jane Street Group LLC bought a new stake in shares of Aimei Health Technology during the 4th quarter valued at about $302,000. Dakota Wealth Management acquired a new position in Aimei Health Technology during the 4th quarter valued at about $406,000. Geode Capital Management LLC acquired a new position in Aimei Health Technology during the 4th quarter valued at about $413,000. Clear Street Group Inc. acquired a new position in Aimei Health Technology during the 3rd quarter valued at about $691,000. Finally, Quarry LP boosted its stake in Aimei Health Technology by 6.4% during the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares during the period. Institutional investors own 45.58% of the company’s stock.

Wall Street Analysts Forecast Growth

AFJK has been the topic of a number of recent analyst reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Friday, March 27th. Wall Street Zen upgraded shares of Aimei Health Technology to a “sell” rating in a report on Saturday, January 17th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Aimei Health Technology currently has an average rating of “Sell”.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.